NVAX
Novavax, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +10.0% ·
share flow +4.1% ·
net new positions +9.1%
· formula
Broad accumulation: rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 11.37K | $125,080 | n/a | n/a |
| Q2 2026 | 98 | +3 | 79.12M | $745.13M | +11 | −8 |
| Q1 2026 | 98 | +8 | 80.71M | $656.76M | +12 | −4 |
| Q4 2025 | 89 | -3 | 88.45M | $594.43M | n/a | −3 |
| Q3 2025 | 19 | +2 | 55.31M | $479.50M | +2 | n/a |
| Q2 2025 | 14 | 0 | 51.16M | $322.31M | n/a | n/a |
| Q1 2025 | 11 | +1 | 21.46M | $137.59M | +1 | n/a |
| Q4 2024 | 10 | -2 | 20.61M | $165.71M | n/a | −2 |
| Q3 2024 | 11 | +2 | 17.18M | $216.96M | +2 | n/a |
| Q2 2024 | 9 | n/a | 15.07M | $190.77M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 7.04M | -8.6% | $45.12M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Coatue Management ✦ | 3.84M | New | $24.60M | 0.1% | New | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 3.76M | +2.9% | $24.13M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 4 | D. E. Shaw & Co. ✦ | 3.26M | -43.7% | $20.90M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 1.67M | +95.4% | $10.69M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 6 | Millennium Management ✦ | 861.40K | -14.0% | $5.52M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | Renaissance Technologies ✦ | 505.25K | -64.1% | $3.24M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | Two Sigma Investments ✦ | 240.19K | +677.1% | $1.54M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 9 | T. Rowe Price ✦ | 179.14K | +123.7% | $1.15M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Wellington Management ✦ | 65.29K | +1.2% | $418,528 | 0.0% | ▲ Add | 3 | SEC ↗ ×4 |
| 11 | AQR Capital Management ✦ | 44.43K | +95.2% | $284,777 | 0.0% | ▲ Add | 3 | SEC ↗ ×5 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Coatue Management | $24.60M | 0.1% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 100.30K shares, $816 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.